| Market Capitalization (Millions $) |
600 |
| Shares
Outstanding (Millions) |
129 |
| Employees |
702 |
| Revenues (TTM) (Millions $) |
203 |
| Net Income (TTM) (Millions $) |
-63 |
| Cash Flow (TTM) (Millions $) |
-30 |
| Capital Exp. (TTM) (Millions $) |
7 |
Business Description
Cytek Biosciences Inc is a leading life science company specializing in the development and manufacture of innovative flow cytometry solutions.
They provide a range of products and services for research, clinical and industrial applications.
Founded in 2011, the company is headquartered in Fremont, California, with additional offices in South Korea and China.
Cytek Biosciences has developed a unique flow cytometer platform called Aurora, which is designed to enable high-resolution analysis of up to 50 parameters in a single cell.
This system is particularly well-suited for applications such as immune monitoring, cell therapy, drug discovery, and cancer research.
The Aurora flow cytometer is also capable of analyzing rare cell populations, including circulating tumor cells and stem cells.
In addition to their cutting-edge technology, Cytek Biosciences offers a range of services to support their customers, including assay development, data analysis, and technical support.
Their expert team of scientists and engineers collaborate with researchers and clinicians around the world to develop customized solutions that meet their specific needs.
Cytek Biosciences is committed to advancing scientific research through their innovative technology and collaborative approach.
With their state-of-the-art flow cytometry solutions, they are helping to drive breakthroughs in fields such as cancer immunotherapy, regenerative medicine, and infectious disease research.
Company Address: 47215 Lakeview Blvd. Fremont 94538 CA
Company Phone Number: 922-9835 Stock Exchange / Ticker: NASDAQ CTKB
|
2.16% 
39.16 %